Literature DB >> 32687756

Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.

Susmita Paladugu1, Anthony A Donato1.   

Abstract

SOURCE CITATION: Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19-preliminary report. N Engl J Med. 2020. [Epub ahead of print]. 32445440.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32687756     DOI： 10.7326/ACPJ202007210-005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  5 in total

Review 1.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

2.  Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.

Authors:  Riadh Badraoui; Mohd Adnan; Fevzi Bardakci; Mousa M Alreshidi
Journal:  Molecules       Date:  2021-01-28       Impact factor: 4.411

3.  The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study.

Authors:  Mahsa Mohajeri; Ehsan Horriatkhah; Reza Mohajery
Journal:  Inflammopharmacology       Date:  2021-10-28       Impact factor: 4.473

4.  Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.

Authors:  Bartosz Puła; Katarzyna Pruszczyk; Ewa Pietrusza; Marta Morawska; Weronika Piszczek; Elżbieta Kalicińska; Agnieszka Szeremet; Jagoda Tryc-Szponder; Ewa Wąsik-Szczepanek; Joanna Drozd-Sokołowska; Helena Krzemień; Aleksandra Rejus; Małgorzata Gajewska; Kamil Wiśniewski; Maciej Wysocki; Alan Majeranowski; Ewa Paszkiewicz-Kozik; Paweł Steckiewicz; Łukasz Szukalski; Łukasz Bołkun; Monika Długosz-Danecka; Krzysztof Giannopoulos; Krzysztof Jamroziak; Ewa Lech-Marańda; Iwona Hus
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

5.  Remdesivir for the treatment of COVID-19.

Authors:  Kelly Ansems; Felicitas Grundeis; Karolina Dahms; Agata Mikolajewska; Volker Thieme; Vanessa Piechotta; Maria-Inti Metzendorf; Miriam Stegemann; Carina Benstoem; Falk Fichtner
Journal:  Cochrane Database Syst Rev       Date:  2021-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.